One-and-Done: Is It Time to Set a Higher Bar for Ablation Success? (Debate redefining success from freedom from symptomatic AF to zero AF burden)

From Burden to Benefit: Does Screening for AF in HFpEF Improve Outcomes?

Choosing Your Pulse: Navigating the Expanding Menu of PFA Catheters and Generators

From Wrist to Risk: Updates from the Heartbeat trial

OPTION, Amulet IDE, and PRAGUE-17: How Trial Data Should Change Our Practice

Discussion

Multidisciplinary and Inclusive Management of AF

Beyond PVI: Do SVC/CS/LAA Ablations Improve Outcomes—or Just Add Risk?

Post-PFA Mapping: Quality Control or Wasted Time?

Patient-Collected Data vs. Clinical Gold Standards: Who Wins in Arrhythmia Detection?

Will Algorithms See What Clinicians Can’t? AI application for ECG and MRI

Discussion

CASTLE-HFpEF: Screening, Burden and Outcomes!

After the Seal: Which Antithrombotics and For How Long?

AF Burden Mediates Outcome Reduction in Patients Undergoing Rhythm Control Therapy

Ablation After PVI: Chase the Triggers or Modify the Atrium?

The New Toys in Afib: Separating Evidence from Enthusiasm

Discussion

When Symptom Relief Matters More Than Freedom from AF

Electrogram guided ablation using PFA: Our experience

GLP-1s Should Be First-Line in Obese AF Patients — Yes or No?

The AF Clinic Experience

No Collateral Damage? Parsing the Reality Behind PFA Safety Claims

Discussion

Does Fibrosis Imaging Still Have a Seat at the AF Table?

Non-Invasive AF Ablation Strategies: Ready for Prime Time or Still Experimental?

Controlling Risk Factors for AF: Easier Said Than Done!

Ablation vs. Meds in HFrEF: One More Trial, or Time to Move On?

Discussion

Anticoaugulation Post Successful Ablation of AF: OCEAN Trial

Where the Evidence Ends: LAAC in Populations Underrepresented in Trials. (cancer, CKD, very elderly)

Will Neuromodulation Replace Substrate Modification in Persistent AF?

AI in mapping AF: revisiting the rotors theory

When Should Genetic Testing Become Routine in AF?

Discussion

MRI Characterization of Arrhythmia-Induced Cardiomyopathy in Persistent AF with LV Dysfunction

PULSEDAY: Turning Awareness Into Action in Atrial Fibrillation

Antiarrhythmic drug therapy post ablation: when and how?

Atrial myopathy in the surgical patient: how does it impact my surgery?

The Business of the EP Lab: How Economics Shape Ablation Availability

Discussion

AF in pulmonary HTN: an emerging clinical entity.

The epidemiology of AF in the era of wearable devices

Atrial Imaging in AF: What to Use, When, and Why

Atrial remodeling from PACs – Time to Reconsider Upstream Therapy?

Integrated PFA Mapping: Lessons from the inspIRE System

Discussion

CCM in Afib Patient

Navigating the AF Backcountry Terrain with AI

Stroke Prevention Without AF? Anticoagulation in the Grey Zone

High Stroke, High Bleed: What Real-World Data Tell Us About Anticoagulation Decisions

Advancements in AI in AF

Discussion

How to Manage Risk of Thromboembolism After Apparent Successful AF Ablation

Anticogulation in CAD and AF

Prevention and Treatment of DRT

Applying Remote Monitoring to Improve Outcomes in AF Management

Anticoagulant or Not? Which Patient with Subclinical AF Should be Anticoagulant

Discussion